Diagnosis tool for primary osteoporosis for postmenopausal women
A technology for primary osteoporosis, applied in the field of diagnosis, which can solve the problems of small number of equipment, high price, and large economic burden for osteoporosis patients
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0054] Example 1 Screening of genes differentially expressed in postmenopausal women with primary osteoporosis and normal menopausal women
[0055] 1. Research object:
[0056] Three postmenopausal women with primary osteoporosis, aged 81, 68, and 79 years old, and two normal postmenopausal women, aged 67 and 68, were selected.
[0057] Inclusion criteria for postmenopausal women with primary osteoporosis: Han postmenopausal women who have menopause for more than 12 months, and all patients have informed consent;
[0058] Exclusion criteria for patients with primary osteoporosis in postmenopausal women include ① Previously received anti-resorptive drugs (including calcitonin, bisphosphonates, estrogen, etc.) or bone-promoting drugs (such as parathyroid hormone, etc.) Treatment (except for those who simply use calcium and / or vitamin D); ② long-term use of glucocorticoids; ③ combined with malignant tumors, bone metastases, and other endocrine and bone metabolism history (such a...
Embodiment 2
[0087] Example 2 QPCR experiment verification of genes differentially expressed in postmenopausal women with primary osteoporosis and normal menopausal women
[0088] 1. Research object:
[0089] Select 30 postmenopausal women with primary osteoporosis and 30 normal postmenopausal women, aged 65-82 years.
[0090] Inclusion criteria for postmenopausal women with primary osteoporosis: Han postmenopausal women who have menopause for more than 12 months, and all patients have informed consent;
[0091] Exclusion criteria for patients with primary osteoporosis in postmenopausal women include ① Previously received anti-resorptive drugs (including calcitonin, bisphosphonates, estrogen, etc.) or bone-promoting drugs (such as parathyroid hormone, etc.) Treatment (except for those who simply use calcium and / or vitamin D); ② long-term use of glucocorticoids; ③ combined with malignant tumors, bone metastases, and other endocrine and bone metabolism history (such as rheumatoid arthritis,...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com


